Home
Conditions
Meningitis, Bacterial

Clinical trial condition

Meningitis, Bacterial

Explore clinical trials studying Meningitis, Bacterial. Study availability and eligibility vary by location and protocol.

134 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Meningitis, Bacterial trial results

Completed

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

NCT03964012

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Centre pour le Développement des Vaccins du Mali, ex-Institut Marchoux, Ministry of Health, BP251 Bamako, Mali

Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine Fajara, The Gambia

View Trial Details

Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

NCT03433482

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: GSK Investigational Site Salvador, Estado de Bahia, Brazil

GSK Investigational Site Natal, Rio Grande do Norte, Brazil

GSK Investigational Site Rio de Janeiro, Brazil

GSK Investigational Site São Paulo, Brazil

View all 49 locations

View Trial Details

Completed

High and Low Resource Interventions to Promote HPV Vaccines

NCT03824093

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: Children's Mercy Hospital Kansas City Kansas City, Missouri, United States

View Trial Details

Completed

Comparison of Two Meningococcal ACWY Conjugate Vaccines

NCT01192997

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Multiple General Practice surgeries Gloucester, Gloucestershire, United Kingdom

Multiple General Practice surgeries Hertford, Hertfordshire, United Kingdom

Health Protection Agency, Immunisation Department, Colindale London, United Kingdom

View Trial Details

Completed

Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years

NCT03587207

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: GSK Investigational Site Hradec Králové, Czechia

View Trial Details

Completed

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

NCT04236960

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Guangdong Provincial Center for Disease Control and Prevention Guangzhou, Guangdong, China

View Trial Details

Completed

Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.

NCT03378258

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +18 more
Locations: Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom

View Trial Details

Completed

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers

NCT00718666

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: GSK Investigational Site Benton, Arkansas, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Antioch, California, United States

GSK Investigational Site Fremont, California, United States

View all 14 locations

View Trial Details

Completed

Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age

NCT01768117

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Frontage Clinical Services (Formally ABR) Hackensack, New Jersey, United States

View Trial Details

Completed

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

NCT00248833

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Walter Reed Army Institute of Research, Clinical Trials Center Silver Spring, Maryland, United States

View Trial Details

Meningitis, Bacterial

Meningitis, Bacterial trial results

Related conditions